Integra LifeSciences Reports Third Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Integra LifeSciences (IART) Tops Q3 EPS by 14c
November 2, 2021 6:12 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.86, $0.14 better than the analyst estimate of $0.72. Revenue for the quarter came in at $386.9 million versus the consensus estimate of $384.58 million.
GUIDANCE:
Integra LifeSciences sees FY2021 EPS of $3.16-$3.20, versus the consensus of $3.04.... More
